CRDN

Views & Analysis

The lessons that can be learned for the future of drug development from the collaboration and innovation in this space.

Views & Analysis

CRDN wants to break down barriers in communication between rare disease patients, HCPs and industry.

News

AstraZeneca's generalised myasthenia gravis (gMG) therapy Klygefa gets CHMP recommendation, alongside several other novel medicines.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.